Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 8017-8017 ◽  
Author(s):  
P. L. McCarthy ◽  
K. Owzar ◽  
K. C. Anderson ◽  
C. C. Hofmeister ◽  
H. Hassoun ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Maintenance Therapy ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Phase Iii ◽  
Cell Transplant

scholarly journals FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

2018 ◽  
Vol 23 (6) ◽  
pp. 734-739 ◽  
Author(s):  
Elizabeth Dianne Pulte ◽  
Andrew Dmytrijuk ◽  
Lei Nie ◽  
Kirsten B. Goldberg ◽  
Amy E. McKee ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Maintenance Therapy ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
Newly Diagnosed ◽  
Fda Approval

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma

2019 ◽  
Vol 55 (6) ◽  
pp. 1188-1190
Author(s):  
Mark A. Fiala ◽  
Venkata Vosuri ◽  
Scott Goldsmith ◽  
Mark A. Schroeder ◽  
Armin Ghobadi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Maintenance Therapy ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant
Sign in / Sign up

Export Citation Format

Share Document